Market Research Logo

Latvia Pharmaceuticals and Healthcare Report Q2 2016

Latvia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The outlook for Latvia's pharmaceutical and healthcare markets will be primarily driven by thegovernment's fiscal austerity measures. The healthcare sector, already severely underfunded, will strugglegiven cuts and place more emphasis on the private sector. Growth in the pharmaceutical sector will belimited by an increasing preference for generic substitution despite a transparent regulatory environment.
0Headline Expenditure Projections

Pharmaceuticals: EUR338mn (USD372mn) in 2015 to EUR353mn (USD377mn) in 2016; +4.4% inlocal currency terms and 1.5% in US dollar terms. Forecast unchanged from previous quarter.

Healthcare: EUR1.01n (USD1.11bn) in 2015 to EUR1.05bn (USD1.13bn) in 2015; +4.2% in localcurrency terms and 1.4% in US dollar terms. Forecast unchanged on previous quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Latvia 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Latvia 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012
2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Latvia 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Latvia 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2012
2020)
OTC Medicine Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Latvia 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Latvia 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Latvia 2014
2020)
Pharmaceuticals & Healthcare Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Latvia Risk/Reward Index
Rewards
Risks
Regulatory Review
Regional Collaboration
Intellectual Property
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Latvia 2010
2015)
Table: Hospitals & Beds, 2006
2010
Table: Hospital Beds by Specialty, 2004
2010
Table: Healthcare Personnel (Latvia 2010
2015)
Table: Healthcare Activity (Latvia 2010
2015)
Research & Development
Biotechnology
Clinical Trials
Epidemiology
Table: Cumulative Reported Cases of HIV and AIDS, 2000
2010
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Grindeks
Olainfarm
Demographic Forecast
Table: Population Headline Indicators (Latvia 1990
2025)
Table: Key Population Ratios (Latvia 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Latvia 1990
2025)
Table: Population By Age Group (Latvia 1990
2025)
Table: Population By Age Group % (Latvia 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report